John Northcott, SVP & Chief Commercial Officer at NEKTAR THERAPEUTICS (NKTR), sold 12,384 shares at $13.83 ($171K) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Open-market sale of $171k NKTR by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.83 | 6,192 | $86K | 50.0% |
| 2 | $13.83 | 6,192 | $86K | 50.0% |
| Total | $13.83 avg | 12,384 | $171K | 100% |
| Filing → |
| NKTR | SELL | 2021-11-17 | $160K | — | Filing → |
| NKTR | SELL | 2021-05-19 | $223K | — | Filing → |
| NKTR | SELL | 2021-02-18 | $687K | — | Filing → |